AU Stock MarketDetailed Quotes

Imricor Medical Systems Inc (IMR)

Watchlist
  • 1.845
  • +0.020+1.10%
20min DelayTrading May 15 13:36 AET
651.99MMarket Cap-15.50P/E (Static)

Imricor Medical Systems Inc (IMR) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 30, 2025
(FY)Dec 30, 2024
(FY)Dec 30, 2023
(FY)Dec 30, 2022
(FY)Dec 30, 2021
(FY)Dec 30, 2020
(FY)Dec 30, 2019
Operating cash flow (direct method)
Cash income from operating activities
-22.52%-19.08M
-20.01%-15.57M
21.40%-12.98M
5.59%-16.51M
-42.99%-17.49M
-84.53%-12.23M
-6.63M
Other cash income from operating activities
-22.52%-19.08M
-20.01%-15.57M
21.40%-12.98M
5.59%-16.51M
-42.99%-17.49M
-84.53%-12.23M
---6.63M
Cash paid
Operating cash flow
-22.52%-19.08M
-20.01%-15.57M
21.40%-12.98M
5.59%-16.51M
-42.99%-17.49M
-84.53%-12.23M
---6.63M
Investing cash flow
Cash flow from continuing investing activities
-28,858.46%-21.71M
9.43%-74.98K
65.34%-82.78K
65.65%-238.86K
10.17%-695.31K
-46.23%-774.03K
-529.34K
Net PPE purchase and sale
-479.23%-434.29K
9.43%-74.98K
65.34%-82.78K
61.83%-238.86K
15.65%-625.75K
-103.39%-741.89K
---364.76K
Net investment purchase and sale
---21.28M
----
----
----
-116.39%-69.56K
80.47%-32.15K
---164.58K
Net other investing changes
----
----
----
----
----
----
---164.58K
Cash from discontinued investing activities
Investing cash flow
-28,858.46%-21.71M
9.43%-74.98K
65.34%-82.78K
65.65%-238.86K
10.17%-695.31K
-46.23%-774.03K
---529.34K
Financing cash flow
Cash flow from continuing financing activities
41.91%43.05M
269.31%30.33M
108.29%8.21M
-65.96%3.94M
-64.92%11.59M
215.98%33.02M
10.45M
Net issuance payments of debt
2.15%-209.14K
-108.15%-213.73K
10,601.99%2.62M
---24.97K
----
----
--3.45M
Net common stock issuance
39.53%43.26M
437.99%31M
33.99%5.76M
-64.66%4.3M
-63.58%12.17M
362.54%33.41M
--7.22M
Net other financing activities
----
-36.31%-452.45K
50.03%-331.93K
19.46%-664.31K
-111.02%-824.8K
-77.66%-390.86K
---220.01K
Cash from discontinued financing activities
Financing cash flow
41.91%43.05M
269.31%30.33M
108.29%8.21M
-65.96%3.94M
-64.92%11.59M
215.98%33.02M
--10.45M
Net cash flow
Beginning cash position
1,789.03%15.71M
-85.38%831.52K
-69.28%5.69M
-26.35%18.52M
397.93%25.14M
217.87%5.05M
--1.59M
Current changes in cash
-84.66%2.25M
403.00%14.69M
62.15%-4.85M
-94.10%-12.81M
-132.95%-6.6M
507.75%20.02M
--3.29M
Effect of exchange rate changes
707.42%1.54M
2,065.09%190.89K
57.29%-9.71K
12.71%-22.74K
-136.74%-26.06K
-57.38%70.93K
--166.4K
End cash Position
24.16%19.5M
1,789.03%15.71M
-85.38%831.52K
-69.28%5.69M
-26.35%18.52M
397.93%25.14M
--5.05M
Free cash from
-24.68%-19.52M
-19.84%-15.65M
22.02%-13.06M
7.54%-16.75M
-39.64%-18.11M
-85.51%-12.97M
---6.99M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(FY)Dec 30, 2025(FY)Dec 30, 2024(FY)Dec 30, 2023(FY)Dec 30, 2022(FY)Dec 30, 2021(FY)Dec 30, 2020(FY)Dec 30, 2019
Operating cash flow (direct method)
Cash income from operating activities -22.52%-19.08M-20.01%-15.57M21.40%-12.98M5.59%-16.51M-42.99%-17.49M-84.53%-12.23M-6.63M
Other cash income from operating activities -22.52%-19.08M-20.01%-15.57M21.40%-12.98M5.59%-16.51M-42.99%-17.49M-84.53%-12.23M---6.63M
Cash paid
Operating cash flow -22.52%-19.08M-20.01%-15.57M21.40%-12.98M5.59%-16.51M-42.99%-17.49M-84.53%-12.23M---6.63M
Investing cash flow
Cash flow from continuing investing activities -28,858.46%-21.71M9.43%-74.98K65.34%-82.78K65.65%-238.86K10.17%-695.31K-46.23%-774.03K-529.34K
Net PPE purchase and sale -479.23%-434.29K9.43%-74.98K65.34%-82.78K61.83%-238.86K15.65%-625.75K-103.39%-741.89K---364.76K
Net investment purchase and sale ---21.28M-------------116.39%-69.56K80.47%-32.15K---164.58K
Net other investing changes ---------------------------164.58K
Cash from discontinued investing activities
Investing cash flow -28,858.46%-21.71M9.43%-74.98K65.34%-82.78K65.65%-238.86K10.17%-695.31K-46.23%-774.03K---529.34K
Financing cash flow
Cash flow from continuing financing activities 41.91%43.05M269.31%30.33M108.29%8.21M-65.96%3.94M-64.92%11.59M215.98%33.02M10.45M
Net issuance payments of debt 2.15%-209.14K-108.15%-213.73K10,601.99%2.62M---24.97K----------3.45M
Net common stock issuance 39.53%43.26M437.99%31M33.99%5.76M-64.66%4.3M-63.58%12.17M362.54%33.41M--7.22M
Net other financing activities -----36.31%-452.45K50.03%-331.93K19.46%-664.31K-111.02%-824.8K-77.66%-390.86K---220.01K
Cash from discontinued financing activities
Financing cash flow 41.91%43.05M269.31%30.33M108.29%8.21M-65.96%3.94M-64.92%11.59M215.98%33.02M--10.45M
Net cash flow
Beginning cash position 1,789.03%15.71M-85.38%831.52K-69.28%5.69M-26.35%18.52M397.93%25.14M217.87%5.05M--1.59M
Current changes in cash -84.66%2.25M403.00%14.69M62.15%-4.85M-94.10%-12.81M-132.95%-6.6M507.75%20.02M--3.29M
Effect of exchange rate changes 707.42%1.54M2,065.09%190.89K57.29%-9.71K12.71%-22.74K-136.74%-26.06K-57.38%70.93K--166.4K
End cash Position 24.16%19.5M1,789.03%15.71M-85.38%831.52K-69.28%5.69M-26.35%18.52M397.93%25.14M--5.05M
Free cash from -24.68%-19.52M-19.84%-15.65M22.02%-13.06M7.54%-16.75M-39.64%-18.11M-85.51%-12.97M---6.99M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More